In individuals with schizophrenia, high-dose antipsychotic medication can induce an upregulation of the brain's dopamine D2 receptors (D2Rs), leading to dopamine supersensitivity (DS) or dopamine supersensitivity psychosis (DSP). Here, DRD2 is linked to schizophrenia.